Dr. Todd Cooper, director of the Pediatric Leukemia/Lymphoma Program and Evans Family Endowed Chair in Pediatric Cancer at Seattle Children’s, is leading a new clinical trial for children and adolescents with AML.
The above image of CPX-351 demonstrates how cytarabine (red dots) and daunorubicin (blue dot) are contained within the liposome. The liposome is used to transport the drugs into the body and into leukemia cells in the bone marrow, which is thought to be safer for the heart.